AI-Powered Radiology Software Receives FDA Clearance
By MedImaging International staff writers Posted on 24 Jan 2019 |
Image: The Quantib Neurodegenerative (ND) software that assists radiologists in reading MRI brain scans has received clearance from the US FDA (Photo courtesy of Quantib).
A radiology software product named Quantib Neurodegenerative (ND) that assists radiologists in reading MRI brain scans has received clearance from the US Food and Drug Administration (FDA) for distribution in the U.S. Built by Quantib B.V. (Rotterdam, ZH), a developer of artificial intelligence (AI) tools for radiologists, the software measures brain atrophy (shrinkage) and detects white matter hyperintensities (WMHs), which are changes in the brain related to, for example, aging, dementia and multiple sclerosis (MS).
Quantib develops AI software for radiologists that uses advanced machine learning techniques to detect changes in tissue sooner than would be possible with the naked eye. The company offers various multiple machine-learning products cleared by the FDA and CE that focus on the quantification and diagnosis of neurodegenerative diseases.
Quantib ND includes fully automatic segmentation of lobes and hippocampus to objectively assess atrophy development. Additionally, it comprises white matter hyperintensity segmentation for easy monitoring neurological changes occurring in for example dementia and MS patients. Reference centile curves, derived from the population-based Rotterdam Scan Study, provide an intuitive tool to compare the patient’s brain volume to the average of an unbiased population.
The software’s follow-up feature tracks neurodegeneration over time. Accurate alignment of images at subsequent time points enable accurate detection and staging of atrophy, combined with WMH tracking. Quantib ND visualizes new and previously identified lesions using color-coded overlays, while its editing feature provides the radiologist with full control of the final results before sending them to the PACS.
“This is an important achievement,” said Arthur Post Uiterweer, CEO of Quantib. “We are very proud to offer physicians an extensive software package for quantitative measurements of neurological changes that can be related to dementia and MS.”
Related Links:
Quantib
Quantib develops AI software for radiologists that uses advanced machine learning techniques to detect changes in tissue sooner than would be possible with the naked eye. The company offers various multiple machine-learning products cleared by the FDA and CE that focus on the quantification and diagnosis of neurodegenerative diseases.
Quantib ND includes fully automatic segmentation of lobes and hippocampus to objectively assess atrophy development. Additionally, it comprises white matter hyperintensity segmentation for easy monitoring neurological changes occurring in for example dementia and MS patients. Reference centile curves, derived from the population-based Rotterdam Scan Study, provide an intuitive tool to compare the patient’s brain volume to the average of an unbiased population.
The software’s follow-up feature tracks neurodegeneration over time. Accurate alignment of images at subsequent time points enable accurate detection and staging of atrophy, combined with WMH tracking. Quantib ND visualizes new and previously identified lesions using color-coded overlays, while its editing feature provides the radiologist with full control of the final results before sending them to the PACS.
“This is an important achievement,” said Arthur Post Uiterweer, CEO of Quantib. “We are very proud to offer physicians an extensive software package for quantitative measurements of neurological changes that can be related to dementia and MS.”
Related Links:
Quantib
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures